Bacterial Skin Infections cream in pharma franchise in Manipur

Bacterial Skin Infections cream PCD pharma franchise in Kohima

Bacterial Skin Infections cream in top pharma company in Chennai

Bacterial Skin Infections cream in pcd pharma supplier in Kalyan-Dombivli

Bacterial Skin Infections creamin phama franchise company in India
Bacterial Skin Infections cream in phama distributor in Thane

Home/Products /clobetasole-0-point-05-neomycin-0-point-5-miconazole-2-cream

About the Product

Description


Diziderm NM Cream is a topical combination cream containing Clobetasol, a potent corticosteroid, Neomycin, an antibiotic, and Miconazole, an antifungal agent. This formulation is designed to provide relief from a wide range of skin conditions caused by inflammation, bacterial infection, and fungal infection.

Clobetasol works as a potent anti-inflammatory, helping to reduce redness, swelling, and itching in conditions like eczema, dermatitis, and psoriasis. It effectively suppresses the immune response in the skin, thus minimizing irritation.

Neomycin, an antibiotic, helps in treating and preventing bacterial infections of the skin, especially in conditions where infection is a risk due to the breakage of the skin’s surface. It fights off bacterial pathogens that might interfere with the healing process.

Miconazole, an antifungal, is highly effective against fungal infections like ringworm, athlete's foot, and candidiasis. It works by disrupting the fungal cell membrane, effectively inhibiting its growth and spreading.

Together, these ingredients create a powerful cream that targets multiple aspects of skin health, providing relief from discomfort and promoting healing. Diziderm NM Cream is ideal for treating inflammatory skin conditions complicated by bacterial or fungal infections.

This combination provides comprehensive treatment, tackling the causes of infection while alleviating symptoms such as itching, burning, and swelling. It is effective for both acute and chronic skin conditions and should be used as directed by a healthcare professional to ensure optimal results.

Potential side effects include skin irritation, burning, itching, dryness, or redness at the application site. Prolonged use may cause skin thinning or steroid-induced skin changes.

Indicated for treating inflammatory skin conditions with bacterial or fungal infections, including eczema, dermatitis, psoriasis, ringworm, athlete’s foot, and candidiasis.

Use only as prescribed. Avoid prolonged use to prevent potential side effects like skin thinning. Do not apply to broken skin or open wounds.

Store in a cool, dry place at 15-25°C. Keep the tube tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Clobetasol 0.05% + Neomycin 0.5% + Miconazole 2% Cream in the PCD pharma franchise market?

This combination has strong demand in the dermatology and anti-infective segment, making it a high-potential product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.

Why should medical distributors include this triple-combination cream in their product range?

Medical distributors and wholesalers can benefit from the consistent demand for this formulation in mixed skin infections involving inflammation, bacterial, and fungal components. It helps strengthen their dermatology and anti-infective portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this cream?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Clobetasol 0.05% + Neomycin 0.5% + Miconazole 2% Cream with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this dermatology formulation?

Wholesalers and medical agencies benefit from steady demand in skin infection treatments, attractive margins, strong market acceptance, and consistent product movement when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this cream?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this dermatology combination can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.